Welcome to Collaborative Strategy Guild Where insights are transformed into actions at the intersection of collaboration, information management, security, and business strategy.
|
This just in (sort of) from Slate.com (via Overcoming Bias):
How to Sell Germ Warfare
A Columbia University study also found no reduction in common infections among inner-city families given free antibacterial hand soap, detergent, and cleaning supplies. The same year, University of Michigan epidemiologist Allison Aiello summarized data on hand hygiene for the FDA and pointed out that three out of four studies showed that alcohol-based hand sanitizers didn’t prevent respiratory infections.
[...]
Today, numerous modern studies show that in randomized trials, meticulous hand-washing, when coupled with other infection control measures like surgical draping and universal gloving, reduce the rate of life-threatening infections during surgery and intensive care… Continue reading: Does it work? Washing your hands edition
This just in (sort of) from the New York Times:
The Great Prostate Mistake
EACH year some 30 million American men undergo testing for prostate-specific antigen, an enzyme made by the prostate. [...] The annual bill for P.S.A. screening is at least $3 billion, with much of it paid for by Medicare and the Veterans Administration. [...] American men have a 16 percent lifetime chance of receiving a diagnosis of prostate cancer, but only a 3 percent chance of dying from it.
Even then, the test is hardly more effective than a coin toss. As I’ve been trying to make clear for many years now, P.S.A. testing can’t detect prostate cancer and, more important, it can’t distinguish… Continue reading: Does it work? P.S.A. Prostate Cancer Tests Edition
|
|
